Patient needs, stakeholder demands, industry innovation, regulatory landscape, and Agilent's evolved business strategy are complex and dynamic. Emphasizing and embedding quality in the execution of clinical trials and vigilance activities assures patient safety, maintains data integrity, fosters regulatory compliance, and contributes to the overall success of in vitro dia